131 related articles for article (PubMed ID: 10916113)
1. Recombinant versus natural human 111In-beta2-microglobulin for scintigraphic detection of Abeta2m amyloid in dialysis patients.
Schäffer J; Burchert W; Floege J; Gielow P; Kionka C; Linke RP; Weiss EH; Shaldon S; Koch KM
Kidney Int; 2000 Aug; 58(2):873-80. PubMed ID: 10916113
[TBL] [Abstract][Full Text] [Related]
2. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
Floege J; Schäffer J; Koch KM
Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
[TBL] [Abstract][Full Text] [Related]
3. Production of recombinant human beta2-microglobulin for scintigraphic diagnosis of amyloidosis in uremia and hemodialysis.
Linke RP; Schäeffer J; Gielow P; Lindner P; Lottspeich F; Plückthun A; Weiss EH
Eur J Biochem; 2000 Feb; 267(3):627-33. PubMed ID: 10651797
[TBL] [Abstract][Full Text] [Related]
4. Imaging techniques in the diagnosis of dialysis-related amyloidosis.
Ketteler M; Koch KM; Floege J
Semin Dial; 2001; 14(2):90-3. PubMed ID: 11264773
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients.
Jadoul M; Garbar C; Vanholder R; Sennesael J; Michel C; Robert A; Noël H; van Ypersele de Strihou C
Kidney Int; 1998 Sep; 54(3):956-9. PubMed ID: 9734623
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis-related amyloidosis: Is it still relevant?
Kaneko S; Yamagata K
Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
[TBL] [Abstract][Full Text] [Related]
7. Expression of beta2-microglobulin and c-fos mRNA: is there an influence of high- or low-flux dialyzer membranes?
Haufe CC; Eismann U; Deppisch RM; Stein G
Kidney Int Suppl; 2001 Feb; 78():S177-81. PubMed ID: 11169006
[TBL] [Abstract][Full Text] [Related]
8. The pathology and changing epidemiology of dialysis-related cardiac beta-2 microglobulin amyloidosis.
Morris AD; Smith RN; Stone JR
Cardiovasc Pathol; 2019; 42():30-35. PubMed ID: 31226597
[TBL] [Abstract][Full Text] [Related]
9. Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis.
Tan SY; Baillod R; Brown E; Farrington K; Soper C; Percy M; Clutterbuck E; Madhoo S; Pepys MB; Hawkins PN
Nephrol Dial Transplant; 1999 Jun; 14(6):1467-71. PubMed ID: 10383009
[TBL] [Abstract][Full Text] [Related]
10. Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro.
Yamaguchi I; Suda H; Tsuzuike N; Seto K; Seki M; Yamaguchi Y; Hasegawa K; Takahashi N; Yamamoto S; Gejyo F; Naiki H
Kidney Int; 2003 Sep; 64(3):1080-8. PubMed ID: 12911560
[TBL] [Abstract][Full Text] [Related]
11. Lysophospholipids induce the nucleation and extension of beta2-microglobulin-related amyloid fibrils at a neutral pH.
Ookoshi T; Hasegawa K; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H
Nephrol Dial Transplant; 2008 Oct; 23(10):3247-55. PubMed ID: 18467373
[TBL] [Abstract][Full Text] [Related]
12. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis.
Yamamoto S; Yamamoto K; Hirao Y; Yamaguchi K; Nakajima K; Sato M; Kawachi M; Domon M; Goto K; Omori K; Iino N; Shimada H; Aoyagi R; Ei I; Goto S; Goto Y; Gejyo F; Yamamoto T; Narita I
Amyloid; 2024 Jun; 31(2):105-115. PubMed ID: 38343068
[TBL] [Abstract][Full Text] [Related]
14. 131I-beta 2-microglobulin scintigraphy in patients with dialysis amyloidosis.
Gejyo F; Kazama JJ; Hasegawa S; Nishi S; Arakawa M; Odano I
Clin Nephrol; 1995 Nov; 44 Suppl 1():S14-8. PubMed ID: 8608655
[TBL] [Abstract][Full Text] [Related]
15. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
Michelis R; Sela S; Ben-Zvi I; Nagler RM
Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
[TBL] [Abstract][Full Text] [Related]
16. C-terminal unfolding of an amyloidogenic β2-microglobulin fragment: ΔN6β2-microglobulin.
Motomiya Y; Higashimoto Y; Uji Y; Suenaga G; Ando Y
Amyloid; 2015 Mar; 22(1):54-60. PubMed ID: 25523495
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of Aβ2M amyloid deposition in bladder cancer in a non-dialysis patient.
Ishii A; Tei Y; Murakami T; Notohara K
Pathol Int; 2019 Apr; 69(4):224-228. PubMed ID: 30707483
[TBL] [Abstract][Full Text] [Related]
18. Circulating level of alpha2-macroglobulin-beta2-microglobulin complex in hemodialysis patients.
Motomiya Y; Ando Y; Haraoka K; Sun X; Iwamoto H; Uchimura T; Maruyama I
Kidney Int; 2003 Dec; 64(6):2244-52. PubMed ID: 14633149
[TBL] [Abstract][Full Text] [Related]
19. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
[TBL] [Abstract][Full Text] [Related]
20. Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis.
García-García M; Argilés ; Gouin-Charnet A; Durfort M; García-Valero J; Mourad G
Kidney Int; 1999 Mar; 55(3):899-906. PubMed ID: 10027926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
